{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T03:57:30Z","timestamp":1791431850338,"version":"4.3.3"},"reference-count":22,"publisher":"Wiley","issue":"3","license":[{"start":{"date-parts":[[2025,2,7]],"date-time":"2025-02-07T00:00:00Z","timestamp":1738886400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["analyticalsciencejournals.onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Biomedical Chromatography"],"published-print":{"date-parts":[[2025,3]]},"abstract":"<jats:title>ABSTRACT<\/jats:title><jats:p>The present manuscript discusses the development of simple, rapid, specific, precision, accuracy stability indicating HPLC method for the analysis of fluphenazine tablets dosage form. The chromatographic separation was achieved using 0.02\u2010M phosphate buffer (pH\u20093.0) and adjusted with orthophosphoric acid solution as a buffer. We mixed buffer, methanol, and acetonitrile in the ratio of 500:300:200 (v\/v\/v) as the mobile phase. The detection of component was made at 254\u2009nm for fluphenazine hydrochloride. We evaluated stress studies under different types of ICH conditions. The optimized HPLC method was validated as per the current ICH guidelines. The validated HPLC method was obtained highly specific with linearity ranging between 2.5 and 120\u2009\u03bcg\/mL of fluphenazine HCl and the correlation coefficient for the drug &gt;\u20090.999. The method showed more than 97% accuracy. In stress studies, the fluphenazine HCl was found to be sensitive in photolytic stress conditions and oxidation stress condition. It is a typical antipsychotic drug and used for the treatment of schizophrenia and bipolar disorder. The method was found to be suitable for the quality control of fluphenazine hydrochloride in the tablet as well as in stability\u2010indicating studies. The method was applied to analyze stability samples.<\/jats:p>","DOI":"10.1002\/bmc.6088","type":"journal-article","created":{"date-parts":[[2025,2,7]],"date-time":"2025-02-07T04:31:24Z","timestamp":1738902684000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Stability\u2010Indicating RP\u2010HPLC Method Development and Validation for the Quantification of Fluphenazine Tablets in Solid Oral Dosage Form"],"prefix":"10.1002","volume":"39","author":[{"ORCID":"https:\/\/orcid.org\/0009-0001-7719-8655","authenticated-orcid":false,"given":"Rama\u00a0Krishna","family":"Myneni","sequence":"first","affiliation":[{"name":"Department of Chemistry Stira Pharmaceuticals LLC  Fairfield New Jersey USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-1091-6016","authenticated-orcid":false,"given":"Hareesh","family":"Divadari","sequence":"additional","affiliation":[{"name":"Department of Chemistry Stira Pharmaceuticals LLC  Fairfield New Jersey USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Srinivasulu","family":"Kasa","sequence":"additional","affiliation":[{"name":"Department of Chemistry Osmania University  Hyderabad India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teja","family":"Kamireddy","sequence":"additional","affiliation":[{"name":"Department of Engineering and Validation August Bioservices  Nashville Tennessee USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-6931-1512","authenticated-orcid":false,"given":"Pranitha","family":"Sambu","sequence":"additional","affiliation":[{"name":"Analytical Research and Development Aurex Laboratories Pvt Ltd  Hyderabad India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-8493-0450","authenticated-orcid":false,"given":"Prasanna\u00a0Kumar","family":"Lankalapalli","sequence":"additional","affiliation":[{"name":"Department of Engineering and Validation Visual Technologies LLC  Plano Texas USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vijaykumar","family":"Chollety","sequence":"additional","affiliation":[{"name":"Analytical Research and Development Ascent Pharmaceuticals Inc.  Central lslip New York USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2025,2,7]]},"reference":[{"key":"e_1_2_7_2_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpha.2012.05.004"},{"key":"e_1_2_7_3_1","doi-asserted-by":"publisher","DOI":"10.1093\/jaoac\/91.6.1309"},{"key":"e_1_2_7_4_1","first-page":"933","volume-title":"British Pharmacopoeia","author":"British Pharmacopoeia Commission","year":"2010"},{"key":"e_1_2_7_5_1","first-page":"238","volume-title":"New Pharmacology","author":"Chen X. Q.","year":"2003"},{"key":"e_1_2_7_6_1","doi-asserted-by":"publisher","DOI":"10.1002\/bmc.5800"},{"key":"e_1_2_7_7_1","doi-asserted-by":"publisher","DOI":"10.1081\/AL\u2010120005971"},{"key":"e_1_2_7_8_1","doi-asserted-by":"publisher","DOI":"10.1081\/AL\u2010120023710"},{"key":"e_1_2_7_9_1","first-page":"1375","volume-title":"Indian Pharmacopoeia","author":"Indian Pharmacopoeia Commission","year":"2010"},{"key":"e_1_2_7_10_1","doi-asserted-by":"publisher","DOI":"10.1093\/chromsci\/19.9.439"},{"key":"e_1_2_7_11_1","doi-asserted-by":"publisher","DOI":"10.21786\/bbrc\/17.1.4"},{"key":"e_1_2_7_12_1","doi-asserted-by":"publisher","DOI":"10.1002\/bmc.6017"},{"key":"e_1_2_7_13_1","doi-asserted-by":"publisher","DOI":"10.1002\/jssc.202300760"},{"key":"e_1_2_7_14_1","doi-asserted-by":"publisher","DOI":"10.1021\/acsomega.3c04589"},{"key":"e_1_2_7_15_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.microc.2023.109835"},{"key":"e_1_2_7_16_1","doi-asserted-by":"publisher","DOI":"10.1002\/bmc.5626"},{"key":"e_1_2_7_17_1","doi-asserted-by":"publisher","DOI":"10.47363\/JPRSR\/2024(5)156"},{"key":"e_1_2_7_18_1","doi-asserted-by":"publisher","DOI":"10.4236\/ajac.2022.1312036"},{"key":"e_1_2_7_19_1","doi-asserted-by":"publisher","DOI":"10.1002\/bmc.5944"},{"key":"e_1_2_7_20_1","doi-asserted-by":"publisher","DOI":"10.20959\/wjpps20204\u201015900"},{"key":"e_1_2_7_21_1","first-page":"1621","volume-title":"European Pharmacopoeia","author":"The European Pharmacopoeial Commission","year":"2005"},{"key":"e_1_2_7_22_1","doi-asserted-by":"publisher","DOI":"10.3797\/scipharm.1411\u201004"},{"key":"e_1_2_7_23_1","first-page":"439","volume-title":"Essentials of Medical Pharmacology","author":"Tripathi K. D.","year":"2011"}],"container-title":["Biomedical Chromatography"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/analyticalsciencejournals.onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/bmc.6088","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T20:12:15Z","timestamp":1760040735000},"score":1,"resource":{"primary":{"URL":"https:\/\/analyticalsciencejournals.onlinelibrary.wiley.com\/doi\/10.1002\/bmc.6088"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,7]]},"references-count":22,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,3]]}},"alternative-id":["10.1002\/bmc.6088"],"URL":"https:\/\/doi.org\/10.1002\/bmc.6088","archive":["Portico"],"relation":{},"ISSN":["0269-3879","1099-0801"],"issn-type":[{"value":"0269-3879","type":"print"},{"value":"1099-0801","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,7]]},"assertion":[{"value":"2024-10-18","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-01-03","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-02-07","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e6088"}}